Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid and Medicare Insurance - The perspective of private and public payers.
Conclusions: A high proportion of patients experienced VOCs across payers. Furthermore, inpatient and SCD-related costs accounted for a significant proportion of total all-cause healthcare costs, which increased with VOC frequency.
PMID: 32815766 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Databases & Libraries | Economics | Health Management | Healthcare Costs | Insurance | Medicaid | Medicare | Sickle Cell Anemia | Study